Jeffrey S. Glenn, Director at Eiger BioPharmaceuticals, Inc. (EIGR), bought 15,460 shares at $12.73 ($197K) on 2016-11-17, disclosed to the SEC on 2016-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.73 | 15,000 | $191K | 97.0% |
| 2 | $12.90 | 460 | $6K | 3.0% |
| Total | $12.74 avg | 15,460 | $197K | 100% |
| Filing → |
| EIGR | BUY | 2020-03-17 | $151K | — | Filing → |
| EIGR | BUY | 2017-09-05 | $143K | — | Filing → |